Patents expiring in 2032

US 8283308

Copolymer-stabilized emulsions

The Regents of the University of California · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2012255544

BEPOTASTINE COMPOSITIONS

PADILLA ANGEL [US] · Granted Thu Oct 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2012259187

DYNAMIC COLORECTAL PDT APPLICATION

KRUIJT BASTIAAN [NL] · Granted Thu Oct 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288530

Method of preparing macromolecular contrast agents and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288537

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288550

Crystalline form of a benzimidazole-carboxamide medicinal compound

Theravance, Inc. · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288400

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288390

Benzofuran derivatives

Takeda Pharmaceutical Company Limited · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288525

Compositions and methods for inhibiting expression of CD45 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288439

Methods and compositions for the inhibition of HIV-1 replication

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288342

Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate

TEVA WOMEN'S HEALTH, INC. · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8287876

Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

United States of America as represented by the Secretary of the Air Force · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8287879

Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use

The Regents of the University of California · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8287857

Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288382

Diaminothiazoles useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288536

Kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288359

Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8287819

Device for synthesis of radiopharmaceutical products

Ion Beam Applications · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8288539

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2511275

Neuartige Piperidinyl-monocarboxylsäuren als S1P1 Rezeptoragonisten

BIOPROJET SOC CIV [FR] · Granted Wed Oct 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Oct 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2012263625

GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY

AICHER DANIEL [DE] · Granted Thu Oct 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293776

Compositions and methods for treating inflammatory conditions of the bowel

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293240

Method of treating drug-resistant cancer

The Regents of the University of Colorado · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293929

Processes and intermediates

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293897

Compounds comprising a spiro-ring and methods of use

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293878

Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors

LEXICON PHARMACEUTICALS, INC. · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293803

Retinoid compounds and their use

Reinnervate Limited · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293869

Polymer conjugates of GLP-1

Nektar Therapeutics · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293707

Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH activity

Syntonix Pharmaceuticals, Inc. · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293275

Spray freeze dry of compositions for pulmonary administration

The Regents of the University of Colorado · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293720

Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

Dogwood Pharmaceuticals, Inc. · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293719

iRNA agents targeting VEGF

Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293267

Method for preparing an antimicrobial cotton of cellulose matrix having chemically and/or physically bonded silver and antimicrobial cotton prepared therefrom

Biotech, Inc. · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293724

Therapeutic applications of fatty acid amide hydrolase inhibitors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293729

Compounds, pharmaceutical composition and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293760

Cyclopamine lactam analogs and methods of use thereof

Infinity Discovery, Inc. · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293764

Compositions and methods for disruption of BRCA2-Rad51 interaction

The Regents of the University of California · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293800

Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293901

MAPK/ERK kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8293272

Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts

Globopharm Pharmazeutische Produktions-und Handelsgesellschaft m.b.H. · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8298606

Methods and compositions for stabilizing the myocardium

The Regents of the University of California · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8298525

Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8299046

Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth

The Regents of the University of California · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8299105

1,2,4-oxadiazole benzoic acid compositions and their use in bioassays

PTC THERAPEUTICS, INC. · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8299261

1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8299100

Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability

Northwestern University · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8299087

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8299050

Method for treating uterine fibroids

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)